<DOC>
	<DOCNO>NCT02670382</DOCNO>
	<brief_summary>The objective study provide critical information regard common distinctive role EPA DHA systemic inflammation lipid metabolism .</brief_summary>
	<brief_title>Role Eicosapentaenoic Acid ( EPA ) Docosahexaenoic Acid ( DHA ) Inflammation Lipids</brief_title>
	<detailed_description>This randomize , placebo-controlled , double-blind , crossover study effect EPA DHA inflammation lipid metabolism 24 men woman metabolic syndrome . The study characterize effect EPA alone DHA alone , relative placebo , plasma biomarkers inflammation , inflammatory cell activation gene expression , plasma lipid lipoprotein level .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Inclusion criterion : fasting plasma TG level 150 500 mg/dL Creactive protein ( CRP ) level ≥2 µg/mL least one follow criterion definition metabolic syndrome : abdominal obesity ( waist circumference &gt; 40 inch men &gt; 35 inch woman ) , hypertension ( blood pressure ≥130/≥85 mmHg use antihypertensive medication ) , fast glucose ≥110 mg/dL . Exclusion criterion : highfish diet ( &gt; 2 fish meals/week ) take fish oil supplement supplement contain EPA DHA allergy sardine allergy sunflower oil regular use antiinflammatory medication ( NSAID , COX inhibitor , corticosteroid ) anticoagulant therapy alcohol consumption &gt; 7 drinks/week uncontrolled thyroid dysfunction insulindependent type 2 diabetes mellitus kidney liver disease smoking alteration coagulation use lipid altering medication</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>